Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For JEN.DE
Valuation Weak
14%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -1.11 2.05 2.07
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 39.20 8.96 6.44
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 0.90 15.80 15.66
Cash -10.62 1.09 1.22
Capex 20.67 -0.35 -0.44
Free Cash Flow -76.80 0.22 0.95
Revenue -12.96 4.52 5.19
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -5.88 0.33 0.35
Operating Margin -29.05 0.11 0.15
ROA -13.87 < 0.005 0.01
ROE -17.60 0.02 0.02
ROIC -23.14 0.01 0.02
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of JEN.DE is permitted for members.
5 Growth
The "Growth Entry" for the Focus of JEN.DE is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of JEN.DE is permitted for members.